Evaluating daily profile of central aortic pressure and reflected pulse wave parameters in climacteric women.

Sergey N Tolstov, Igor A Salov, Anton R Kiselev, Andrey P Rebrov
Author Information
  1. Sergey N Tolstov: Department of Therapy with Courses in Cardiology, Functional Diagnostic and Geriatrics, Saratov State Medical University, Saratov, Russia. ORCID
  2. Igor A Salov: Department of Obstetrics and Gynecology, Saratov State Medical University, Saratov, Russia. ORCID
  3. Anton R Kiselev: Department of Innovative Cardiological Information Technology, Institute of Cardiological Research, Saratov State Medical University, Saratov, Russia. kiselev@cardio-it.ru. ORCID
  4. Andrey P Rebrov: Department of Hospital Therapy, Saratov State Medical University, Saratov, Russia. ORCID

Abstract

INTRODUCTION: Structural and functional changes of the vascular wall in women occur already at the very early stages of reproductive aging. An emergence of applanation tonometry made it possible to evaluate arterial stiffness and central hemodynamic parameters non-invasively, which considerably expanded the information that had been provided previously by invasive methods used for studying these parameters during cardiac catheterization. Whereas a few studies have assessed central aortic pressure (CAP) parameters and reflected pulse wave in women at different phases of their reproductive aging, none investigated the daily profile of CAP and reflected pulse wave parameters in women undergoing different stages of the menopause.
BACKGROUND: assessment of the daily variability in CAP and daily profile of amplification and augmentation of pulse blood pressure (PBP) in women at different menopause phases.
METHODS: The study involved 384 climacteric women. The first group included 168 women undergoing perimenopause, the second group comprised of 216 women in their early postmenopausal stage. A 24-h blood pressure (BP) monitoring in the brachial artery and aorta (BPLab® Vasotens® system, Petr Telegin LLC, Russia) was performed via the measurements of the following indicators: systolic blood pressure (SBP), pulse blood pressure (PBP), central aortic systolic pressure (CASP), central aortic pulse pressure (CAPP), aortic augmentation index (AIxao), and pulse pressure amplification (PPA).
RESULTS: When investigating PPA values in the brachial artery and aorta, we detected smaller amplification and higher aortic augmentation index at night than in daytime, which reflected a disproportionately higher CAP level during night hours. This pattern was more pronounced in postmenopausal women. We calculated the logistic regression equation (adjusted R = 0.49, log-likelihood = - 50.3, chi-square (19) = 97.6, p < 0.001), in which dependent variable was represented by the menopausal status, whereas body mass index with all indicators of a 24-h BP monitoring represented independent variables. In this model, two indicators (body mass index and AIxao) were, independently of each other, associated significantly with the menopause phases. Differences among women at various climacteric phases in terms of remaining indicators of a 24-h BP monitoring, apparently, matched the differences in their body mass index values.
CONCLUSION: Rising CAP, in combination with declining PPA and augmenting reflected pulse wave amplitude, may be associated with an increased risk of cardiovascular complications.

Keywords

References

  1. Int J Hypertens. 2017;2017:6265823 [PMID: 29085674]
  2. Horm Metab Res. 2013 Sep;45(10):701-8 [PMID: 23681753]
  3. Ann N Y Acad Sci. 2002 Jun;966:143-57 [PMID: 12114268]
  4. Hypertension. 2017 Jul;70(1):148-157 [PMID: 28483919]
  5. Post Reprod Health. 2018 Mar;24(1):44-49 [PMID: 29338561]
  6. Menopause. 2012 Apr;19(4):387-95 [PMID: 22343510]
  7. J Am Coll Cardiol. 2012 May 15;59(20):1771-7 [PMID: 22575315]
  8. Vasc Health Risk Manag. 2011;7:649-56 [PMID: 22140314]
  9. Eur Heart J. 2006 Nov;27(21):2588-605 [PMID: 17000623]
  10. Cell Biochem Biophys. 2015 Jul;72(3):709-17 [PMID: 25627546]
  11. J Clin Endocrinol Metab. 2012 Dec;97(12):4692-700 [PMID: 22969140]
  12. Adv Clin Chem. 2015;72:1-75 [PMID: 26471080]
  13. Kardiologiia. 2018 SJan;(S1):56-64 [PMID: 29768162]
  14. Physiol Rep. 2017 Dec;5(23): [PMID: 29208690]
  15. J Hypertens. 1997 Sep;15(9):987-93 [PMID: 9321746]
  16. Atherosclerosis. 2015 Aug;241(2):507-32 [PMID: 26117398]
  17. J Am Heart Assoc. 2016 Mar 25;5(3):e002693 [PMID: 27016574]
  18. Angiology. 2008 Apr-May;59(2 Suppl):54S-7S [PMID: 18515273]
  19. Hypertension. 2013 Jun;61(6):1168-76 [PMID: 23630950]
  20. Atherosclerosis. 2017 Mar;258:26-33 [PMID: 28182996]
  21. Vasc Health Risk Manag. 2014 Apr 28;10:247-51 [PMID: 24812515]
  22. Gynecol Endocrinol. 2018 Jan;34(1):78-82 [PMID: 28675704]
  23. Curr Opin Nephrol Hypertens. 2011 Mar;20(2):133-8 [PMID: 21178615]
  24. Adv Exp Med Biol. 2017;1043:227-256 [PMID: 29224098]
  25. Gynecol Endocrinol. 1997 Oct;11(5):341-55 [PMID: 9385535]
  26. N Engl J Med. 1999 Jun 10;340(23):1801-11 [PMID: 10362825]
  27. J Clin Endocrinol Metab. 2013 Nov;98(11):4507-15 [PMID: 24092827]
  28. Med Devices (Auckl). 2014 May 02;7:91-7 [PMID: 24833924]
  29. Physiol Rep. 2017 Sep;5(17): [PMID: 28904082]

MeSH Term

Antihypertensive Agents
Aorta
Arterial Pressure
Blood Pressure Monitoring, Ambulatory
Brachial Artery
Female
Heart Disease Risk Factors
Humans
Hypertension
Menopause
Middle Aged
Perimenopause
Postmenopause
Predictive Value of Tests
Pulse Wave Analysis
Risk Assessment
Time Factors
Vascular Stiffness

Chemicals

Antihypertensive Agents

Word Cloud

Created with Highcharts 10.0.0pressurewomenpulseaorticindexcentralparametersCAPreflectedwavephasesdailyamplificationblooddifferentprofilemenopauseaugmentationclimacteric24-hBPmonitoringPPAbodymassindicatorsearlystagesreproductiveagingstiffnessundergoingPBPgrouppostmenopausalbrachialarteryaortasystolicAIxaovalueshighernightrepresentedassociatedINTRODUCTION:Structuralfunctionalchangesvascularwalloccuralreadyemergenceapplanationtonometrymadepossibleevaluatearterialhemodynamicnon-invasivelyconsiderablyexpandedinformationprovidedpreviouslyinvasivemethodsusedstudyingcardiaccatheterizationWhereasstudiesassessednoneinvestigatedBACKGROUND:assessmentvariabilityMETHODS:studyinvolved384firstincluded168perimenopausesecondcomprised216stageBPLab®Vasotens®systemPetrTeleginLLCRussiaperformedviameasurementsfollowingindicators:SBPCASPCAPPRESULTS:investigatingdetectedsmallerdaytimedisproportionatelylevelhourspatternpronouncedcalculatedlogisticregressionequationadjustedR = 049log-likelihood = - 503chi-square19 = 976p < 0001dependentvariablemenopausalstatuswhereasindependentvariablesmodeltwoindependentlysignificantlyDifferencesamongvarioustermsremainingapparentlymatcheddifferencesCONCLUSION:RisingcombinationdecliningaugmentingamplitudemayincreasedriskcardiovascularcomplicationsEvaluatingArterialAugmentationCentralMenopausePulse

Similar Articles

Cited By

No available data.